Novartis paid Takeda $3.4 billion for its FDA-approved dry eye drug Xiidra during the Japanese ... has just announced FDA approval of a phase 3 trial for eye drops containing tivanisiran, in ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

Alembic is introducing dorzolamide ophthalmic solution, 2%, which is the generic of Merck Sharp & Dohme ‘s Trusopt. Dorzolamide ophthalmic solution is indicated in the treatment of elevated ...

for its Abbreviated New Drug Application for Loteprednol Etabonate Ophthalmic Gel, 0.38%. Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of post ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

Aldeyra Therapeutics' dogged persistence with its drug eye disease therapy reproxalap ... are well-entrenched therapies like Novartis' Xiidra (lifitegrast) and AbbVie's Restasis (cyclosporine ...

Systane Lubricant Eye Drops in a green and pink carton design ... also announced the recall on its website. The U.S. Food and Drug Administration published the recall on Monday.